Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Anorexia 6Cachexia 5Weight Loss 3Breast Neoplasms 3Neoplasms 2Lung Neoplasms 2Body Weight 2Squamous Cell Carcinoma of Head and Neck 1Prosthesis Failure 1Pancreatic Neoplasms 1Nutrition Disorders 1Menorrhagia 1Liver Neoplasms 1Leiomyoma 1Hot Flashes 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Body Weight Changes 1

Interventions

Megestrol Acetate 2Exercise 2Resistance Training 1Metformin 1Diet Therapy 1Caseins 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Body Weight × Megestrol Acetate × Clear all
NCT00637728 2016-06-23

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

Par Pharmaceutical, Inc.

Phase 3 Terminated
5 enrolled 8 charts
GastrointestinalThoracic

Anorexia, Body Weight, Cachexia, Lung Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT00637806 2016-05-02

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Par Pharmaceutical, Inc.

Phase 3 Terminated
4 enrolled 6 charts

Anorexia, Body Weight, Cachexia, Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡